tiprankstipranks
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market

Compare Arvinas Holding Company (ARVN) vs. Competitors

1,044 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arvinas Holding Company
$10.82
$692.06M
-9.53
63.44%
8 Buy
6 Hold
0 Sell
Moderate Buy
AnaptysBio
$70.10
$2.02B
-101.81
331.65%
9 Buy
1 Hold
0 Sell
Strong Buy
Meiragtx Holdings
$8.97
$730.57M
-5.60
76.92%
4 Buy
0 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.17
$931.05M
213.33%
9 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$16.10
$1.40B
-13.39
372.14%
10 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.12
$1.38B
-6.67
108.08%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARVN
Arvinas Holding Company
10.82
3.87
55.68%
ANAB
AnaptysBio
70.10
52.93
308.27%
MGTX
Meiragtx Holdings
8.97
3.77
72.50%
CMPX
Compass Therapeutics
5.17
3.47
204.12%
OLMA
Olema Pharmaceuticals
16.10
12.33
327.06%
BCAX
Bicara Therapeutics Inc.
21.12
10.35
96.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts